Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
Bioventus (Nasdaq: BVS) has announced it will release its third quarter fiscal year 2024 financial results before market opening on Tuesday, November 5, 2024. The company will host a conference call at 8:30 a.m. Eastern Time on the same day, featuring management discussion of results and business updates. Investors can join via phone at 1-833-636-0497 or watch the live webcast on the company's investor relations website. The webcast recording will remain available for replay until November 4, 2025.
Bioventus (Nasdaq: BVS) ha annunciato che rilascerà i propri risultati finanziari del terzo trimestre dell'anno fiscale 2024 prima dell'apertura del mercato martedì 5 novembre 2024. L'azienda ospiterà una conferenza telefonica alle 8:30 ora dell'Est dello stesso giorno, durante la quale il management discuterà i risultati e gli aggiornamenti aziendali. Gli investitori possono partecipare telefonicamente al numero 1-833-636-0497 o guardare la diretta sul sito web delle relazioni con gli investitori dell'azienda. La registrazione della webconferenza sarà disponibile per la visione fino al 4 novembre 2025.
Bioventus (Nasdaq: BVS) ha anunciado que publicará sus resultados financieros del tercer trimestre del año fiscal 2024 antes de la apertura del mercado el martes 5 de noviembre de 2024. La compañía llevará a cabo una conferencia telefónica a las 8:30 a.m. hora del Este del mismo día, donde la gerencia discutirá los resultados y las actualizaciones del negocio. Los inversores pueden unirse por teléfono al 1-833-636-0497 o ver la transmisión en vivo en el sitio web de relaciones con inversores de la empresa. La grabación de la transmisión estará disponible para su reproducción hasta el 4 de noviembre de 2025.
Bioventus (Nasdaq: BVS)는 2024 회계연도 3분기 재무 결과를 2024년 11월 5일 화요일 시장 개장 전에 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 기준으로 오전 8시 30분에 경영진이 결과 및 사업 업데이트에 대해 논의하는 컨퍼런스 콜을 주최할 것입니다. 투자자들은 전화 1-833-636-0497로 참여하거나 회사의 투자자 관계 웹사이트에서 라이브 웹캐스트를 시청할 수 있습니다. 웹캐스트 녹화는 2025년 11월 4일까지 다시 볼 수 있습니다.
Bioventus (Nasdaq: BVS) a annoncé qu'il publiera ses résultats financiers du troisième trimestre de l'exercice 2024 avant l'ouverture des marchés le mardi 5 novembre 2024. La société organisera une conférence téléphonique à 8h30, heure de l'Est, le même jour, où la direction discutera des résultats et des mises à jour commerciales. Les investisseurs peuvent se joindre par téléphone au 1-833-636-0497 ou regarder le webinaire en direct sur le site web des relations investisseurs de l'entreprise. L'enregistrement du webinaire sera disponible en replay jusqu'au 4 novembre 2025.
Bioventus (Nasdaq: BVS) hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal des Geschäftsjahres 2024 vor der Markteröffnung am Dienstag, den 5. November 2024, veröffentlichen wird. Das Unternehmen wird am selben Tag um 8:30 Uhr Eastern Time eine Telefonkonferenz veranstalten, in der das Management über die Ergebnisse und Geschäftsaktualisierungen diskutieren wird. Anleger können telefonisch unter 1-833-636-0497 teilnehmen oder die Live-Webcast auf der Investor-Relations-Website des Unternehmens ansehen. Die Aufzeichnung des Webcasts wird bis zum 4. November 2025 verfügbar sein.
- None.
- None.
DURHAM, N.C., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2024 before the market opens on Tuesday, November 5, 2024. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call.
A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until November 4, 2025.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com
FAQ
When will Bioventus (BVS) report Q3 2024 earnings?
How can I listen to Bioventus (BVS) Q3 2024 earnings call?
How long will Bioventus (BVS) Q3 2024 earnings webcast be available?
